General Information of the Compound
| Compound ID |
CP0408912
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
8-[6-(3,3-dimethylazetidin-1-yl)pyrazin-2-yl]-2,8-diazaspiro[4.5]decan-3-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H25N5O
|
||||||||||||||||||
| Molecular Weight |
315.421
|
||||||||||||||||||
| Canonical SMILES |
CC1(C)CN(C1)c1cncc(n1)N1CCC2(CNC(=O)C2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H25N5O/c1-16(2)11-22(12-16)14-9-18-8-13(20-14)21-5-3-17(4-6-21)7-15(23)19-10-17/h8-9H,3-7,10-12H2,1-2H3,(H,19,23)
Show/Hide
|
||||||||||||||||||
| InChIKey |
XQBNNOFAFYZWBB-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03119, Cytochrome P450 11B1, mitochondrial
Protein ID: PT03120, Cytochrome P450 11B2, mitochondrial